182 related articles for article (PubMed ID: 34233962)
1. The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.
Sharma N; Smadbeck JB; Abdallah N; Zepeda-Mendoza C; Binder M; Pearce KE; Asmann YW; Peterson JF; Ketterling RP; Greipp PT; Bergsagel PL; Rajkumar SV; Kumar SK; Baughn LB
Clin Cancer Res; 2021 Oct; 27(19):5430-5439. PubMed ID: 34233962
[TBL] [Abstract][Full Text] [Related]
2. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
Goldsmith SR; Fiala MA; Dukeman J; Ghobadi A; Stockerl-Goldstein K; Schroeder MA; Tomasson M; Wildes TM; Vij R
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):285-289. PubMed ID: 30792096
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.
Walker BA
Methods Mol Biol; 2018; 1792():71-95. PubMed ID: 29797253
[TBL] [Abstract][Full Text] [Related]
4. Using MMRFBiolinks R-Package for Discovering Prognostic Markers in Multiple Myeloma.
Settino M; Cannataro M
Methods Mol Biol; 2022; 2401():289-314. PubMed ID: 34902136
[TBL] [Abstract][Full Text] [Related]
5. Revealing the impact of structural variants in multiple myeloma.
Rustad EH; Yellapantula VD; Glodzik D; Maclachlan KH; Diamond B; Boyle EM; Ashby C; Blaney P; Gundem G; Hultcrantz M; Leongamornlert D; Angelopoulos N; Agnelli L; Auclair D; Zhang Y; Dogan A; Bolli N; Papaemmanuil E; Anderson KC; Moreau P; Avet-Loiseau H; Munshi NC; Keats JJ; Campbell PJ; Morgan GJ; Landgren O; Maura F
Blood Cancer Discov; 2020 Nov; 1(3):258-273. PubMed ID: 33392515
[TBL] [Abstract][Full Text] [Related]
6. Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
Clin Cancer Res; 2024 Feb; 30(3):575-585. PubMed ID: 37939148
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
Barwick BG; Neri P; Bahlis NJ; Nooka AK; Dhodapkar MV; Jaye DL; Hofmeister CC; Kaufman JL; Gupta VA; Auclair D; Keats JJ; Lonial S; Vertino PM; Boise LH
Nat Commun; 2019 Apr; 10(1):1911. PubMed ID: 31015454
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multiple algorithms to reliably detect structural variants in pears.
Liu Y; Zhang M; Sun J; Chang W; Sun M; Zhang S; Wu J
BMC Genomics; 2020 Jan; 21(1):61. PubMed ID: 31959124
[TBL] [Abstract][Full Text] [Related]
9. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Smadbeck J; Peterson JF; Pearce KE; Pitel BA; Figueroa AL; Timm M; Jevremovic D; Shi M; Stewart AK; Braggio E; Riggs DL; Bergsagel PL; Vasmatzis G; Kearney HM; Hoppman NL; Ketterling RP; Kumar S; Rajkumar SV; Greipp PT; Baughn LB
Blood Cancer J; 2019 Dec; 9(12):103. PubMed ID: 31844041
[TBL] [Abstract][Full Text] [Related]
10. Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma.
Abdallah N; Baughn LB; Rajkumar SV; Kapoor P; Gertz MA; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Go RS; Hwa YL; Fonder A; Hobbs M; Lin Y; Leung N; Kourelis T; Warsame R; Siddiqui M; Lust J; Kyle RA; Ketterling R; Bergsagel L; Greipp P; Kumar SK
Clin Cancer Res; 2020 Dec; 26(24):6581-6588. PubMed ID: 33008815
[TBL] [Abstract][Full Text] [Related]
11. Detection of structural variation using target captured next-generation sequencing data for genetic diagnostic testing.
Mu W; Li B; Wu S; Chen J; Sain D; Xu D; Black MH; Karam R; Gillespie K; Farwell Hagman KD; Guidugli L; Pronold M; Elliott A; Lu HM
Genet Med; 2019 Jul; 21(7):1603-1610. PubMed ID: 30563988
[TBL] [Abstract][Full Text] [Related]
12. Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients.
Ha J; Lee H; Shin S; Cho H; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
J Mol Diagn; 2022 Jan; 24(1):48-56. PubMed ID: 34656761
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis.
Okada Y; Teramoto M; Tachi N; Kawamura T; Horiuchi T; Kato S; Maekawa T; Osawa Y; Kobayashi S; Kimura F
Acta Haematol; 2022; 145(6):582-591. PubMed ID: 35016184
[TBL] [Abstract][Full Text] [Related]
14. Impact of rare structural variant events in newly diagnosed multiple myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
bioRxiv; 2023 Jan; ():. PubMed ID: 36711679
[TBL] [Abstract][Full Text] [Related]
15. Best practices for the assessment of measurable residual disease (MRD) in multiple myeloma.
Bal S; Costa LJ
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 1(1):1-20. PubMed ID: 33843859
[TBL] [Abstract][Full Text] [Related]
16. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
17. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
Einerson RR; Law ME; Blair HE; Kurtin PJ; McClure RF; Ketterling RP; Flynn HC; Dogan A; Remstein ED
Leukemia; 2006 Oct; 20(10):1790-9. PubMed ID: 16888615
[TBL] [Abstract][Full Text] [Related]
18. Microhomology-mediated end joining drives complex rearrangements and overexpression of
Mikulasova A; Ashby C; Tytarenko RG; Qu P; Rosenthal A; Dent JA; Ryan KR; Bauer MA; Wardell CP; Hoering A; Mavrommatis K; Trotter M; Deshpande S; Yaccoby S; Tian E; Keats J; Auclair D; Jackson GH; Davies FE; Thakurta A; Morgan GJ; Walker BA
Haematologica; 2020 Apr; 105(4):1055-1066. PubMed ID: 31221783
[No Abstract] [Full Text] [Related]
19. Prognostic significance of esterase gene expression in multiple myeloma.
Kumari R; Majumder MM; Lievonen J; Silvennoinen R; Anttila P; Nupponen NN; Lehmann F; Heckman CA
Br J Cancer; 2021 Apr; 124(8):1428-1436. PubMed ID: 33531688
[TBL] [Abstract][Full Text] [Related]
20. Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients.
Walker BA; Wardell CP; Brioli A; Boyle E; Kaiser MF; Begum DB; Dahir NB; Johnson DC; Ross FM; Davies FE; Morgan GJ
Blood Cancer J; 2014 Mar; 4(3):e191. PubMed ID: 24632883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
